FDA Approves mySentry monitor from Medtronic
Minneapolis-based Medtronic, Inc., has announced that the US Food and Drug Administration has given it the go-ahead to market its mySentry monitor, which allows caregivers
Minneapolis-based Medtronic, Inc., has announced that the US Food and Drug Administration has given it the go-ahead to market its mySentry monitor, which allows caregivers
At the end of 2011 Medtronic announced the Food and Drug Administration (FDA) approval of iPro2, a next generation Professional continuous glucose monitoring (CGM) system
Medtronic is offering one team of Juniors the opportunity to take part in its 5th Junior Cup football competition. The team will consist of ten players aged
Medtronic has launched the Enlite Sensor, the newest and most advanced glucose sensor for continuous glucose monitoring (CGM), in the UK combining greater comfort with
This neat little bundle is the Mio, the newest infusion set to be added to the Medtronic range. An all-in-one set, the Mio has an
The Paradigm Veo System combines an insulin pump with continuous glucose monitoring (CGM). The CGM takes the form of a separate sensor and transmitter to
Diabetes patients in the UK and Ireland will be the first in the world to use a new technology which mimics key elements of the